Chiome Bioscience Inc. (4583.T)
JPY 129.0
(0.78%)
JPY 129.0
(0.78%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.22 Billion JPY | 1.84% |
| 2022 | -1.24 Billion JPY | 16.02% |
| 2021 | -1.47 Billion JPY | -14.38% |
| 2020 | -1.29 Billion JPY | 7.84% |
| 2019 | -1.4 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -259.93 Million JPY | 14.5% |
| 2024 Q1 | -304.02 Million JPY | -0.82% |
| 2023 Q3 | -254.81 Million JPY | 41.55% |
| 2023 Q2 | -435.97 Million JPY | -91.48% |
| 2023 Q1 | -227.68 Million JPY | -5.75% |
| 2023 FY | -1.22 Billion JPY | 1.84% |
| 2023 Q4 | -301.55 Million JPY | -18.34% |
| 2022 Q3 | -256.55 Million JPY | 0.0% |
| 2022 FY | -1.24 Billion JPY | 16.02% |
| 2022 Q4 | -215.31 Million JPY | 16.08% |
| 2021 FY | -1.47 Billion JPY | -14.38% |
| 2020 FY | -1.29 Billion JPY | 7.84% |
| 2019 FY | -1.4 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 417.713% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -131.54% |
| GNI Group Ltd. | 8.09 Billion JPY | 115.073% |
| Linical Co., Ltd. | 338.26 Million JPY | 460.668% |
| Trans Genic Inc. | 4.08 Million JPY | 29965.802% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 15.156% |
| Soiken Holdings Inc. | -662.2 Million JPY | -84.236% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 983.079% |
| AnGes, Inc. | -7.43 Billion JPY | 83.597% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 5.288% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 83.039% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 753.485% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -56.412% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | -5.822% |
| CanBas Co., Ltd. | -1.2 Billion JPY | -0.911% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -50.173% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -276.942% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 14.209% |
| PeptiDream Inc. | 3.03 Billion JPY | 140.187% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 37.064% |
| Ribomic Inc. | -1.02 Billion JPY | -19.115% |
| SanBio Company Limited | -2.64 Billion JPY | 53.857% |
| Healios K.K. | -3.82 Billion JPY | 68.087% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -4.446% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 18.098% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 14.648% |
| StemRIM | -2.02 Billion JPY | 39.663% |
| CellSource Co., Ltd. | 923.14 Million JPY | 232.159% |
| FunPep Company Limited | -933.41 Million JPY | -30.705% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -42.834% |
| Stella Pharma Corporation | -763.74 Million JPY | -59.741% |
| TMS Co., Ltd. | -960.04 Million JPY | -27.08% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | -7.965% |
| Cuorips Inc. | -632.18 Million JPY | -92.985% |
| K Pharma,Inc. | 260.33 Million JPY | 568.643% |
| Takara Bio Inc. | 1.48 Billion JPY | 182.434% |
| ReproCELL Incorporated | -31.41 Million JPY | -3783.552% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 4725.135% |
| StemCell Institute Inc. | 310.98 Million JPY | 492.313% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 952.152% |
| CellSeed Inc. | -846.53 Million JPY | -44.119% |